Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
VBI Vaccines (VBIV)
NASDAQ:VBIV
VBI Vaccines (VBIV) Stock Price & Analysis
2,187 Followers
VBIV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.24 - $1.86
Previous Close$0.29
Volume880.37K
Average Volume (3M)939.71K
Market Cap
$73.78M
Enterprise Value$63.38M
Total Cash (Recent Filing)$62.63M
Total Debt (Recent Filing)$52.23M
Price to Earnings (P/E)-0.6
Beta1.88
Next Earnings
May 08, 2023EPS Estimate
-$0.08Last Dividend Ex-Date
Jul 14, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding230,648,396
10 Day Avg. Volume822,056
30 Day Avg. Volume939,709
Standard Deviation0.24
R-Squared0.17
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)5.86
Price to Sales (P/S)178.13
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue58.58
Enterprise Value/Gross Profit-6.22
Enterprise Value/Ebitda-0.60
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
VBI Vaccines News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VBIV FAQ
What was VBI Vaccines’s price range in the past 12 months?
VBI Vaccines lowest stock price was $0.23 and its highest was $1.86 in the past 12 months.
What is VBI Vaccines’s market cap?
Currently, no data Available
When is VBI Vaccines’s upcoming earnings report date?
VBI Vaccines’s upcoming earnings report date is May 08, 2023 which is in 44 days.
How were VBI Vaccines’s earnings last quarter?
VBI Vaccines released its earnings results on Mar 13, 2023. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.07 by -$0.01.
Is VBI Vaccines overvalued?
According to Wall Street analysts VBI Vaccines’s price is currently Overvalued.
Does VBI Vaccines pay dividends?
VBI Vaccines pays a Notavailable dividend of $4.52 which represents an annual dividend yield of N/A. See more information on VBI Vaccines dividends here
What is VBI Vaccines’s EPS estimate?
VBI Vaccines’s EPS estimate is -$0.08.
How many shares outstanding does VBI Vaccines have?
VBI Vaccines has 258,257,500 shares outstanding.
What happened to VBI Vaccines’s price movement after its last earnings report?
VBI Vaccines reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.07. Following the earnings report the stock price went up 2.857%.
Which hedge fund is a major shareholder of VBI Vaccines?
Among the largest hedge funds holding VBI Vaccines’s share is Perceptive Advisors LLC. It holds VBI Vaccines’s shares valued at 20M.
---
VBI Vaccines Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
VBIV Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 163.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.72%
12-Months-Change
Fundamentals
Return on Equity
-108.92%
Trailing 12-Months
Asset Growth
-26.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
VBI Vaccines
VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding VBIV
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold VBIV. The ETFs are listed according to market value of VBIV within the ETF
---
Tenaya Therapeutics
―
Oric Pharmaceuticals
―
Anixa Biosciences
―
Precision BioSciences
―
Alaunos Therapeutics
―
---